β2-Microglobulin Amyloidosis in Chronic Renal Failure
- 11 October 1990
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (15) , 1070-1071
- https://doi.org/10.1056/nejm199010113231514
Abstract
In recent years β2-microglobulin amyloidosis has been increasingly recognized as a complication of dialysis.1 , 2 The incidence of amyloid deposits and associated arthropathies increases with the lengthening of dialysis therapy; hence, techniques or materials used in dialysis are believed by some authors to have a major role in the development of β2-microglobulin amyloidosis.3 The case that we describe below, however, demonstrates that dialysis is not an absolute prerequisite for the generation of β2-microglobulin amyloid fibrils.Keywords
This publication has 4 references indexed in Scilit:
- Erosive Spondyloarthropathy in Long-Term Dialysis Patients: Relationship to Severe HyperparathyroidismMayo Clinic Proceedings, 1988
- Hemodialysis is not essential for the development of destructive spondylarthropathy in patients with chronic renal failureArthritis & Rheumatism, 1987
- Synovial amyloidosis in patients undergoing long‐term hemodialysisArthritis & Rheumatism, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985